#1 Clinical Trials Search in Europe

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

  • A study testing AZD3632 alone or with other anticancer drugs in adults with acute leukemia or myelodysplastic syndromes with HOX gene overexpression

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Denmark Germany Italy

  • Study of DDCART-CD19 cells with cyclophosphamide and fludarabine for children and young adults (up to 39 years) with recurrent acute leukemia after stem cell transplant

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Greece

  • Study on CD19+ Lymphoid Disease Using Genetically Modified T Cells for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin’s Lymphoma

    Recruiting

    1 1
    Investigated drugs:
    Germany

  • Study of Inotuzumab Ozogamicin Alone and with Drug Combination for Children with Relapsed or Refractory Acute Lymphoblastic Leukemia

    Recruiting

    1 1 1
    Investigated drugs:
    Austria Belgium Czechia Denmark Finland France +7

  • Long-Term Safety Study of MB-CART19.1, MB-CART20.1, and Zamtocabtagene Autoleucel for Patients with Advanced Melanoma or B-Cell Malignancies

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • A Study of Blinatumomab in Children with Relapsed or Treatment-Resistant B Cell Acute Lymphoblastic Leukemia with Remaining Disease Traces

    Not yet recruiting

    1 1
    Investigated drugs:
    France Italy The Netherlands

  • A study to evaluate the safety and effectiveness of subcutaneous blinatumomab in adults and adolescents with relapsed, refractory, or minimal residual disease positive B-cell precursor acute lymphoblastic leukemia.

    Not yet recruiting

    1 1 1
    Investigated drugs:
    Belgium France Germany Italy The Netherlands Romania +1

  • A Study Testing the Safety of CD19-Targeted CAR T-Cell Therapy in Children and Young Adults with Relapsed or Refractory B-Cell Cancers

    Not yet recruiting

    1 1
    Investigated drugs:
    The Netherlands

  • Study on Tisagenlecleucel for High-Risk B-Cell Acute Lymphoblastic Leukemia in Pediatric and Young Adult Patients with Minimal Residual Disease

    Not recruiting

    1 1 1
    Investigated drugs:
    Belgium Denmark France Italy The Netherlands Norway +2